Remus Pharmaceuticals Ltd.

Market Capital
₹744 Cr.
P/E
87.47
Share Price
₹ 5049.0 0 (0%)

Remus Pharmaceuticals Ltd.

Quick View
₹ 5049.0 0 (0%)
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Forensics
ROE
Net Profit Margin is responsible for ROE increase over last 10 years
Other Income
Other Income is not affecting ratios of the company
Revenue Recognition
insufficient data
Pledge
insufficient data
Working Capital
Working Capital of the company seems to be under control
Depreciation Effect
Depreciation accounting is not leading to increase in profits
Capex vs ROCE
ROCE of the company has increased over the last three years
Contingent Liabilities
insufficient data
Retail Holding
insufficient data
Share price
insufficient data
Current vs Historic Valuation
insufficient data
Promoter Holding
Promoter has not sold any shares in the last 90 days
Debt
Company should not have issues servicing its debt
ROE
Latest
52.64%
3yr Average
42.16%
5yr Average
42.16%
Net Profit Margin
Latest
13.7%
3yr Average
8.69%
5yr Average
8.69%
ROCE
Latest
70.03%
3yr Average
53.54%
5yr Average
53.54%
Debt to Equity
Latest
0.03
3yr Average
0.1
5yr Average
0.1
Company Filing
Show Previous Years
Discussions & Analysis
[]
timeline
Sign Up for Free